Nanjing, China

Yanbin Wang

This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Bioheng Therapeutics Limited. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yanbin Wang. Retrieved from https://idiyas.com/inventor/yanbin-wang-dgzchxro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 7.6

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yanbin Wang: Innovator in Antibody Development

Introduction

Yanbin Wang is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. His work is crucial for advancing therapeutic options in various medical conditions.

Latest Patents

Yanbin Wang holds a patent for a "CD7-TARGETING HUMANIZED ANTIBODY AND USE THEREOF." This innovative patent showcases his expertise in creating targeted therapies that can improve treatment outcomes for patients.

Career Highlights

Yanbin Wang is currently employed at Bioheng Therapeutics Limited, where he continues to push the boundaries of antibody research. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking advancements in biotechnology.

Collaborations

Yanbin Wang works alongside his coworker, Xiaoyan Jiang, who is also involved in innovative research at Bioheng Therapeutics Limited. Their collaboration enhances the potential for developing effective therapies.

Conclusion

Yanbin Wang's contributions to the field of biotechnology, particularly through his patent and work at Bioheng Therapeutics Limited, highlight his role as an influential inventor. His ongoing research promises to lead to significant advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…